Medcura

Riverdale, MD · Founded 2007 · Privately Held (backing)

Developer of biopolymer-based hemostatic device designed to manage surgical bleeding in clinical, military, and consumer environments. Medcura is based in Riverdale, MD and was founded in 2007. It was valued at $112 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $55.9 million across 4 recorded rounds; the latest was a $28.5 million early-stage round in Apr 2025.

PMV mark · valuation
$112.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$55.9M
Last round
Early Stage VC
Apr 2025

Who backs Medcura?

18 investors
InvestorType
US National Science FoundationOther
United States Department of War—
TEDCOVenture capital
New York AngelsAngel
Robin Hood VenturesAngel
Denniston Family OfficeFamily office
Sung Capital PartnersFamily office
Aspira Capital Management—
Aubrey Capital—
DMV Angel Group—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Medcura investors

18 investors are on record for Medcura, including US National Science Foundation, United States Department of War, TEDCO and New York Angels. By type, the record holds 2 family offices, 2 angel investors and 1 venture capital firm. The early-stage round in Apr 2025 drew 174 investors.

Free account
More of Medcura with a free account
  • ·The complete investor list: 18 names
  • ·Watch Medcura: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like Medcura. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View